Stability of commercial solutions of 5-fluorouracil for continuos infusion in an ambulatory pump

Cancer Chemotherapy and Pharmacology

Volumn 46, Issue 6, 2000, Pages 501-506

  Fournet, Alexandra ^a   Gilard, Véronique ^a   Malet Martino, Myriam ^a   Martino, Robert ^a   Canal, Pierre ^b   De Forni, Marcel ^b  

^a Université Paul Sabatier   (France)

^b INSTITUT CLAUDIUS REGAUD   (France)

Author keywords

Ambulatory pump; Cardiotoxic compounds; Fluorouracil; Lyophilizate; Stability

Indexed keywords

ACETALDEHYDE; CARDIOTOXIN; FLUORIDE ION; FLUOROACETALDEHYDE; FLUOROMALONIC ACID SEMIALDEHYDE; FLUOROURACIL; UNCLASSIFIED DRUG;

ARTICLE; CARDIOTOXICITY; CONCENTRATION (PARAMETERS); DRUG IMPURITY; DRUG INFUSION; DRUG PACKAGING; DRUG STABILITY; FLUORINATION; FREEZE DRYING; INFUSION PUMP; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL;

EID: 0033647041     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800000182     Document Type: Article

References (24)

1. The anticancer drug 5-fluorouracil is metabolized by the isolated perfused rat liver and in rats into highly toxic fluoroacetate
2. Stabilite des preparations de 5-fluorouracile en fonction de differents parametres
3. Stability of fluorouracil in polypropylene syringes and ethylene vinyl acetate infusion-pump reservoirs
4. Cardiotoxicity of the antiproliferative compound fluorouracil
5. Effects of PVC bags sterilization process on the 5-fluorouracil stability
6. Cardiotoxicity of high-dose continuous infusion fluorouracil: A prospective clinical study
7. Cardiotoxicity of commercial 5-fluorouracil vials stems from the alkaline hydrolysis of this drug
8. The Tris formulation of fluorouracil is more cardiotoxic than the sodium salt formulations
9. A novel metabolite of 5-fluorouracil in humans: 2-fluoro-3-hydroxypropionic acid
10. Magnetic resonance spectroscopy: A powerful tool for drug metabolism studies
11. Long-term stability of 5-fluorouracil stored in PVC bags and in ambulatory pump reservoirs
12. Stability of the principal cytostatic agents during storage at unusual temperatures
13. Etude de compatibilite physicochimique 5-fluorouracile (nouvelle preparation francaise)-acide folinique
14. Long-term stability of 5-fluorouracil and folinic acid admixtures
15. The stability of carboplatin, diamorphine, 5-fluorouracil and mitozantrone infusions in an ambulatory pump under storage and prolonged 'in-use' conditions
16. The oral fluorouracil prodrugs
17. Stability of fluorouracil, cytarabine, or doxorubicin hydrochloride in ethylene vinylacetate portable infusion-pump reservoirs
18. Fluorouracil
19. Compatibility of morphine, baclofen, floxuridine and fluorouracil in an implantable medication pump
20. Stability studies on admixtures of 5-fluorouracil with carboplatin and 5-fluorouracil with heparin for administration in continuous infusion regimens
21. Stability of fluorouracil administered through four portable infusion pumps
22. Stability of deferoxamine mesylate, floxuridine, fluorouracil, hydromorphone hydrochloride, lorazepam, and midazolam hydrochloride in polypropylene infusion-pump syringes
23. Study of the stability of pyrimidine series cytostatics, ftorafur and fluorouracil injections
24. Stability of fluorouracil-metoclopramide hydrochloride admixtures